These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26784885)

  • 1. Panax notoginseng saponins ameliorate impaired arterial vasodilation in SHRSP.Z-Lepr(fa) /lzmDmcr rats with metabolic syndrome.
    Wu T; Sun J; Kagota S; Maruyama K; Wakuda H; Shinozuka K
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):459-67. PubMed ID: 26784885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Lepr fa/IzmDmcr rats with metabolic syndrome.
    Kagota S; Maruyama K; Wakuda H; McGuire JJ; Yoshikawa N; Nakamura K; Shinozuka K
    Vascul Pharmacol; 2014 Oct; 63(1):46-54. PubMed ID: 25109437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
    Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Can J Physiol Pharmacol; 2011 May; 89(5):355-64. PubMed ID: 21619437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
    Kagota S; Fukushima K; Umetani K; Tada Y; Nejime N; Nakamura K; Mori H; Sugimura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1035-43. PubMed ID: 20659132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic oxidative-nitrosative stress impairs coronary vasodilation in metabolic syndrome model rats.
    Kagota S; Maruyama K; Tada Y; Fukushima K; Umetani K; Wakuda H; Shinozuka K
    Microvasc Res; 2013 Jul; 88():70-8. PubMed ID: 23571030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats.
    Maruyama K; Kagota S; McGuire JJ; Wakuda H; Yoshikawa N; Nakamura K; Shinozuka K
    J Vasc Res; 2015; 52(4):232-43. PubMed ID: 26760532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Dependent Differences in the Influence of Perivascular Adipose Tissue on Vasomotor Functions in Metabolic Syndrome.
    Kagota S; Iwata S; Maruyama K; McGuire JJ; Shinozuka K
    Metab Syndr Relat Disord; 2017 Jun; 15(5):233-239. PubMed ID: 28358621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes to vascular protease-activated receptor 2 in metabolic syndrome: a relationship between oxidative stress, receptor expression, and endothelium-dependent vasodilation.
    Maruyama K; Kagota S; McGuire JJ; Wakuda H; Yoshikawa N; Nakamura K; Shinozuka K
    Can J Physiol Pharmacol; 2017 Apr; 95(4):356-364. PubMed ID: 28103056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
    Fan J; Liu D; He C; Li X; He F
    J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular Adipose Tissue-Enhanced Vasodilation in Metabolic Syndrome Rats by Apelin and
    Kagota S; Maruyama-Fumoto K; Iwata S; Shimari M; Koyanagi S; Shiokawa Y; McGuire JJ; Shinozuka K
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597883
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang X; Zhou C; Miao L; Tan Y; Zhou Y; Cheong MS; Huang Y; Wang Y; Yu H; Cheang WS
    Oxid Med Cell Longev; 2021; 2021():4722797. PubMed ID: 34527173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notoginsenoside Ft1 activates both glucocorticoid and estrogen receptors to induce endothelium-dependent, nitric oxide-mediated relaxations in rat mesenteric arteries.
    Shen K; Leung SW; Ji L; Huang Y; Hou M; Xu A; Wang Z; Vanhoutte PM
    Biochem Pharmacol; 2014 Mar; 88(1):66-74. PubMed ID: 24440742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panax notoginseng saponins improve the erectile dysfunction in diabetic rats by protecting the endothelial function of the penile corpus cavernosum.
    Lin F; Gou X
    Int J Impot Res; 2013; 25(6):206-11. PubMed ID: 23595104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
    Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
    J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
    Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
    Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome.
    Kagota S; Maruyama-Fumoto K; Shimari M; McGuire JJ; Shinozuka K
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):501-509. PubMed ID: 31420755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
    Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat.
    Zheng M; Qu L; Lou Y
    Phytother Res; 2008 May; 22(5):597-604. PubMed ID: 18398927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome.
    Kagota S; Yamaguchi Y; Tanaka N; Kubota Y; Kobayashi K; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Life Sci; 2006 Feb; 78(11):1187-96. PubMed ID: 16188278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1 -receptor blocker doxazosin.
    López-Farré A; Rodriguez-Feo JA; García-Colis E; Gomez J; López-Blaya A; Fortes J; de Andrés R; Rico L; Casado S
    J Hypertens; 2002 Mar; 20(3):463-70. PubMed ID: 11875314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.